Christopher Lopez
About Christopher Lopez
Christopher Lopez is an Oncology Territory Business Manager at Bristol-Myers Squibb in the Greater Columbus Area, with extensive experience in pharmaceutical sales and a background in aviation management.
Company
Christopher Lopez currently works at Bristol-Myers Squibb in the role of Oncology Territory Business Manager. His work contributes to the company's focus on specialized treatments for cancer, specifically skin and lung cancers through medicines like Opdivo and Yervoy. His efforts have positioned Bristol-Myers Squibb as a leading name in oncology within the Greater Columbus Area.
Education and Expertise
Christopher Lopez attended The Ohio State University, where he studied Aviation Management and earned a Bachelor of Science. His diverse educational background provides him with unique perspectives in his current role in the pharmaceutical industry. Lopez leverages his knowledge to effectively manage territories and develop strategic initiatives in oncology sales.
Professional Background
Christopher Lopez has a rich history in the pharmaceutical industry, beginning with his role at Pfizer as a Pharmaceutical Sales Specialist from 2002 to 2005. He subsequently worked at Novartis as a Pharmaceutical Sales Consultant from 2005 to 2010, followed by a seven-year tenure at Amgen as a Biopharmaceutical Sales Representative. From 2017 to 2019, Lopez was part of Pfizer's Inflammation & Immunology Specialty Care. This extensive experience across top-tier pharmaceutical companies has endowed him with deep industry insights and expertise.
Achievements
During his career, Christopher Lopez has earned several notable achievements. At Bristol-Myers Squibb, he led his team to win the Oncology Ours to Own Contest for highest regional growth with Yervoy in treating certain melanomas. He was named the territory lead for melanoma in 2021 and completed intensive training to facilitate access to Opdivo and Yervoy programs. His efforts resulted in earning the #1 regional ranking for his territory, qualifying for Bristol-Myers Squibb’s Winner’s Circle for the first time. Lopez has also successfully promoted key treatments, contributing to the company's recognition as a top oncology company.